Heartbeam, Inc. Common Stock (BEAT) is a publicly traded Healthcare sector company. As of November 12, 2026, BEAT trades at $0.41 with a market cap of $23.16M and a P/E ratio of -0.99. BEAT moved -1.22% today. Year to date, BEAT is -85.07%; over the trailing twelve months it is -75.51%. Its 52-week range spans $0.36 to $4.00. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces BEAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover BEAT: 0 strong buy, 2 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $3.50.
| Metric | Value |
|---|---|
| Price | $0.41 |
| Market Cap | $23.16M |
| P/E Ratio | -0.99 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.00 |
| 52-Week Low | $0.36 |
| Volume | 388.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-21.02M |
| Gross Margin | 0.00% |
3 analysts cover BEAT: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.